FI904474A0 - Rekombinanta aprotininvarianter, gentekniskt foerfarande foer framstaellning av homogent processerade aprotininvarianter och deras terapeutiska anvaendning. - Google Patents

Rekombinanta aprotininvarianter, gentekniskt foerfarande foer framstaellning av homogent processerade aprotininvarianter och deras terapeutiska anvaendning.

Info

Publication number
FI904474A0
FI904474A0 FI904474A FI904474A FI904474A0 FI 904474 A0 FI904474 A0 FI 904474A0 FI 904474 A FI904474 A FI 904474A FI 904474 A FI904474 A FI 904474A FI 904474 A0 FI904474 A0 FI 904474A0
Authority
FI
Finland
Prior art keywords
processing
varianter
aprotine
recommended
frequency
Prior art date
Application number
FI904474A
Other languages
English (en)
Other versions
FI104724B (fi
Inventor
Juergen Ebbers
Dietrich Hoerlein
Michael Schedel
Rathindra Das
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI904474A0 publication Critical patent/FI904474A0/fi
Application granted granted Critical
Publication of FI104724B publication Critical patent/FI104724B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI904474A 1989-09-13 1990-09-11 Menetelmä aprotiniinivarianttien valmistamiseksi FI104724B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3930522A DE3930522A1 (de) 1989-09-13 1989-09-13 Rekombinante aprotinin-varianten - gentechnisches verfahren zur mikrobiellen herstellung von homogen prozessierten aprotinin-varianten sowie die therapeutische anwendung derselben
DE3930522 1989-09-13

Publications (2)

Publication Number Publication Date
FI904474A0 true FI904474A0 (fi) 1990-09-11
FI104724B FI104724B (fi) 2000-03-31

Family

ID=6389306

Family Applications (1)

Application Number Title Priority Date Filing Date
FI904474A FI104724B (fi) 1989-09-13 1990-09-11 Menetelmä aprotiniinivarianttien valmistamiseksi

Country Status (15)

Country Link
US (1) US5164482A (fi)
EP (1) EP0419878B1 (fi)
JP (1) JP2916228B2 (fi)
KR (1) KR0169976B1 (fi)
AT (1) ATE113074T1 (fi)
AU (1) AU632361B2 (fi)
CA (1) CA2025070C (fi)
DD (1) DD299311A5 (fi)
DE (2) DE3930522A1 (fi)
DK (1) DK0419878T3 (fi)
ES (1) ES2062235T3 (fi)
FI (1) FI104724B (fi)
HU (1) HU213582B (fi)
IL (1) IL95618A (fi)
ZA (1) ZA907266B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2208511A (en) * 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
US5591603A (en) * 1987-08-28 1997-01-07 Novo Nordisk A/S Process for preparing aprotinin and aprotinin analogs in yeast cells
DK450187D0 (da) * 1987-08-28 1987-08-28 Novo Industri As Fremgangsmaade til fremstilling af proteiner
US5056341A (en) * 1989-06-08 1991-10-15 Sanyo Electric Co., Ltd. Washing machine
US5231010A (en) * 1989-09-13 1993-07-27 Bayer Aktiengesellschaft Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
IL99585A0 (en) * 1990-10-01 1992-08-18 Novo Nordisk As Aprotinin analogues,their production and pharmaceutical compositions containing them
DE4417353A1 (de) * 1994-05-18 1996-01-25 Bayer Ag Verfahren zur Herstellung von rekombinantem Aprotinin und rekombinanten Aprotinin Varianten mit der natürlichen N-terminlaen Sequenz
US5786328A (en) * 1995-06-05 1998-07-28 Genentech, Inc. Use of kunitz type plasma kallikrein inhibitors
US5780265A (en) * 1995-06-05 1998-07-14 Genentech, Inc. Kunitz type plasma kallikrein inhibitors
DE19629982A1 (de) 1996-07-25 1998-01-29 Bayer Ag Aprotinin-Varianten mit verbesserten Eigenschaften
DE19725014A1 (de) * 1997-06-13 1998-12-17 Bayer Ag Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten
WO2003033009A2 (en) * 2001-07-10 2003-04-24 Omnio Ab Novel drug targets for arthritis
US20060218667A1 (en) * 2004-10-12 2006-09-28 Vojdani Fakhrieh S Plant-produced recombinant aprotinin and aprotinin variants
CA2619657C (en) 2005-09-16 2016-01-26 Bayer Cropscience Sa Transplastomic plants expressing lumen-targeted protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037806A (en) * 1985-02-22 1991-08-06 Monsanto Company Biologically active method using somatotropins
GB2188322A (en) * 1986-03-26 1987-09-30 Bayer Ag Aprotinin and analogues thereof produced by a recombinant host
GB2208511A (en) * 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
DK225488D0 (da) * 1988-04-26 1988-04-26 Novo Industri As Polypeptid
DK450187D0 (da) * 1987-08-28 1987-08-28 Novo Industri As Fremgangsmaade til fremstilling af proteiner

Also Published As

Publication number Publication date
HU213582B (en) 1997-08-28
EP0419878A1 (de) 1991-04-03
IL95618A0 (en) 1991-06-30
ZA907266B (en) 1991-07-31
FI104724B (fi) 2000-03-31
IL95618A (en) 1996-09-12
CA2025070C (en) 2001-01-02
JPH03197496A (ja) 1991-08-28
US5164482A (en) 1992-11-17
EP0419878B1 (de) 1994-10-19
AU632361B2 (en) 1992-12-24
AU6245390A (en) 1991-03-21
KR0169976B1 (ko) 1999-02-01
DK0419878T3 (da) 1994-11-21
JP2916228B2 (ja) 1999-07-05
ES2062235T3 (es) 1994-12-16
DE59007498D1 (de) 1994-11-24
HUT62031A (en) 1993-03-29
CA2025070A1 (en) 1991-03-14
KR910006483A (ko) 1991-04-29
ATE113074T1 (de) 1994-11-15
HU905877D0 (en) 1991-03-28
DE3930522A1 (de) 1991-03-21
DD299311A5 (de) 1992-04-09

Similar Documents

Publication Publication Date Title
FI904474A0 (fi) Rekombinanta aprotininvarianter, gentekniskt foerfarande foer framstaellning av homogent processerade aprotininvarianter och deras terapeutiska anvaendning.
PT73161A (fr) Procede pour la preparation de derives de n-(vynblastinoyl-23) aux amino-acids et peptides et son application terapeutique
PT85225A (en) Process for the preparation of acyl derivatives and of pharmaceutical compositions containing the same
DK0662827T4 (da) Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer
HUT54303A (en) Process for producing medicaments comprising cytokin, suitable for systemic treatment of preneoplastic lesions
IL72985A0 (en) Homogenous immune interferon fragment,its manufacture and pharmaceutical compositions containing it
IL58759A (en) Process for purifying proteins,pure and homogeneous interferon species obtained thereby and pharmaceutical compositions containing them
HU906244D0 (en) Process for the production or compounds which eliminate the effect of retrovirus-like proteases and process for the production of medical preparations containing them
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
FI840748A0 (fi) Kinolonkarbonsyror, foerfarande foer deras framstaellning och dessa innehaollande antibakteriella aemnen
IL81964A0 (en) Microbially produced aprotinin and homologues,process,expression vector and recombinant host for their preparation and pharmaceutical compositions containing them
AU587989B2 (en) DMA fragments, expression vectors, proteins, hosts, and process for production of the proteins
TW221056B (fi)
GB2082911B (en) Pharmaceutical compositions containing amino acids for promoting the healing of wounds
GR900100772A (el) Μέ?οδος για την παρασκευή φαρμακευτικών σκευασμάτων.
DE3474672D1 (en) Alkylated fab or fc fragments of human igg, process for their preparation and pharmaceutical compositions
IL76929A0 (en) Preparation for the treatment of hemophilia a inhibitor patients and a process for producing such a preparation
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
HUT47148A (en) Process for producing homogenous recombinant immune interferon fragments and pharmaceutical compositions comprising them
ZA894945B (en) Strontium salt,process for the preparation thereof and pharmaceutical compositions containing it
ZA837332B (en) Novel galenic form of sulpiride,process for its preparation and medicament comprising said novel form
DE69431603D1 (de) Oligopeptide hergeleitet von fragmenten des c-reaktiven proteins
DE3560262D1 (en) Hexapeptide, process for its preparation and pharmaceutical compositions thereof
HUP0000812A2 (hu) Myelin bázikus fehérje peptid-fragmentumai az azokat tartalmazó gyógyszerkészítmények és felhasználásuk a sclerosis multiplex kezelésére
ATE184287T1 (de) Derivate von therapeutisch in der blutgerinnungskaskade wirksamen peptiden, verfahren zur herstellung und sie enthaltende pharmazeutische zubereitungen

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BAYER AKTIENGESELLSCHAFT